Oncternal Therapeutics (ONCT) Q2 2023 Earnings

10AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.24
-0.21
-0.18
-0.15

Details

Expected EPS
-0.16
Actual EPS
-0.15
Surprise EPS
0.01
Surprise Percent
+6.25%

Description

Oncternal Therapeutics (ONCT) has reported earnings of -0.15 per share for Q2 2023.

0 Comments

Share your thoughts